BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26477622)

  • 1. Current and Future Chemotherapy for Chagas Disease.
    Gaspar L; Moraes CB; Freitas-Junior LH; Ferrari S; Costantino L; Costi MP; Coron RP; Smith TK; Siqueira-Neto JL; McKerrow JH; Cordeiro-da-Silva A
    Curr Med Chem; 2015; 22(37):4293-312. PubMed ID: 26477622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chagas disease drug discovery: toward a new era.
    Chatelain E
    J Biomol Screen; 2015 Jan; 20(1):22-35. PubMed ID: 25245987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.
    Urbina JA
    Acta Trop; 2010; 115(1-2):55-68. PubMed ID: 19900395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput screening for anti-Trypanosoma cruzi drug discovery.
    Alonso-Padilla J; Rodríguez A
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3259. PubMed ID: 25474364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
    Duschak VG
    Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances in drug discovery for Chagas disease.
    Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
    Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational challenges of animal models in Chagas disease drug development: a review.
    Chatelain E; Konar N
    Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic screening approaches for Chagas disease drug discovery.
    Chatelain E; Ioset JR
    Expert Opin Drug Discov; 2018 Feb; 13(2):141-153. PubMed ID: 29235363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chagas disease: Globalization and new hope for its cure].
    Belaunzarán ML
    Rev Argent Microbiol; 2015; 47(2):85-7. PubMed ID: 26028584
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel drug discovery for Chagas disease.
    Moraes CB; Franco CH
    Expert Opin Drug Discov; 2016; 11(5):447-55. PubMed ID: 26967915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).
    Rodriguez JB; Falcone BN; Szajnman SH
    Expert Opin Ther Pat; 2016 Sep; 26(9):993-1015. PubMed ID: 27376456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Methods to Discover Compounds for the Treatment of Chagas Disease.
    Cortés-Ruiz EM; Palomino-Hernández O; Rodríguez-Hernández KD; Espinoza B; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2018; 113():119-142. PubMed ID: 30149904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutical approaches under investigation for treatment of Chagas disease.
    Bahia MT; Diniz Lde F; Mosqueira VC
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1225-37. PubMed ID: 24855989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?
    Lepesheva GI
    Expert Opin Drug Discov; 2013 Dec; 8(12):1479-89. PubMed ID: 24079515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
    Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
    Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
    Gaspar L; Coron RP; KongThoo Lin P; Costa DM; Perez-Cabezas B; Tavares J; Roura-Ferrer M; Ramos I; Ronin C; Major LL; Ciesielski F; Pemberton IK; MacDougall J; Ciapetti P; Smith TK; Cordeiro-da-Silva A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006180. PubMed ID: 29357372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.